1 Study Coverage 1.1 Drug-Eluting Bioabsorbable Stents Product Introduction 1.2 Market Segments 1.3 Key Drug-Eluting Bioabsorbable Stents Manufacturers Covered: Ranking by Revenue 1.4 Market by Type 1.4.1 Global Drug-Eluting Bioabsorbable Stents Market Size Growth Rate by Type 1.4.2 Serolimus and Paclitaxel Drug-Eluting Stents 1.4.3 Sirolimus Drug Eluting Stents 1.5 Market by Application 1.5.1 Global Drug-Eluting Bioabsorbable Stents Market Size Growth Rate by Application 1.5.2 Coronary Artery Diseases 1.5.3 Peripheral Artery Diseases 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Drug-Eluting Bioabsorbable Stents Market Size, Estimates and Forecasts 2.1.1 Global Drug-Eluting Bioabsorbable Stents Revenue 2015-2026 2.1.2 Global Drug-Eluting Bioabsorbable Stents Sales 2015-2026 2.2 Global Drug-Eluting Bioabsorbable Stents, Market Size by Producing Regions: 2015 VS 2020 VS 2026 2.2.1 Global Drug-Eluting Bioabsorbable Stents Retrospective Market Scenario in Sales by Region: 2015-2020 2.2.2 Global Drug-Eluting Bioabsorbable Stents Retrospective Market Scenario in Revenue by Region: 2015-2020 3 Global Drug-Eluting Bioabsorbable Stents Competitor Landscape by Players 3.1 Drug-Eluting Bioabsorbable Stents Sales by Manufacturers 3.1.1 Drug-Eluting Bioabsorbable Stents Sales by Manufacturers (2015-2020) 3.1.2 Drug-Eluting Bioabsorbable Stents Sales Market Share by Manufacturers (2015-2020) 3.2 Drug-Eluting Bioabsorbable Stents Revenue by Manufacturers 3.2.1 Drug-Eluting Bioabsorbable Stents Revenue by Manufacturers (2015-2020) 3.2.2 Drug-Eluting Bioabsorbable Stents Revenue Share by Manufacturers (2015-2020) 3.2.3 Global Drug-Eluting Bioabsorbable Stents Market Concentration Ratio (CR5 and HHI) (2015-2020) 3.2.4 Global Top 10 and Top 5 Companies by Drug-Eluting Bioabsorbable Stents Revenue in 2019 3.2.5 Global Drug-Eluting Bioabsorbable Stents Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Drug-Eluting Bioabsorbable Stents Price by Manufacturers 3.4 Drug-Eluting Bioabsorbable Stents Manufacturing Base Distribution, Product Types 3.4.1 Drug-Eluting Bioabsorbable Stents Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Drug-Eluting Bioabsorbable Stents Product Type 3.4.3 Date of International Manufacturers Enter into Drug-Eluting Bioabsorbable Stents Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Market Size by Type (2015-2026) 4.1 Global Drug-Eluting Bioabsorbable Stents Market Size by Type (2015-2020) 4.1.1 Global Drug-Eluting Bioabsorbable Stents Sales by Type (2015-2020) 4.1.2 Global Drug-Eluting Bioabsorbable Stents Revenue by Type (2015-2020) 4.1.3 Drug-Eluting Bioabsorbable Stents Average Selling Price (ASP) by Type (2015-2026) 4.2 Global Drug-Eluting Bioabsorbable Stents Market Size Forecast by Type (2021-2026) 4.2.1 Global Drug-Eluting Bioabsorbable Stents Sales Forecast by Type (2021-2026) 4.2.2 Global Drug-Eluting Bioabsorbable Stents Revenue Forecast by Type (2021-2026) 4.2.3 Drug-Eluting Bioabsorbable Stents Average Selling Price (ASP) Forecast by Type (2021-2026) 4.3 Global Drug-Eluting Bioabsorbable Stents Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Market Size by Application (2015-2026) 5.1 Global Drug-Eluting Bioabsorbable Stents Market Size by Application (2015-2020) 5.1.1 Global Drug-Eluting Bioabsorbable Stents Sales by Application (2015-2020) 5.1.2 Global Drug-Eluting Bioabsorbable Stents Revenue by Application (2015-2020) 5.1.3 Drug-Eluting Bioabsorbable Stents Price by Application (2015-2020) 5.2 Drug-Eluting Bioabsorbable Stents Market Size Forecast by Application (2021-2026) 5.2.1 Global Drug-Eluting Bioabsorbable Stents Sales Forecast by Application (2021-2026) 5.2.2 Global Drug-Eluting Bioabsorbable Stents Revenue Forecast by Application (2021-2026) 5.2.3 Global Drug-Eluting Bioabsorbable Stents Price Forecast by Application (2021-2026) 6 North America 6.1 North America Drug-Eluting Bioabsorbable Stents by Country 6.1.1 North America Drug-Eluting Bioabsorbable Stents Sales by Country 6.1.2 North America Drug-Eluting Bioabsorbable Stents Revenue by Country 6.1.3 U.S. 6.1.4 Canada 6.2 North America Drug-Eluting Bioabsorbable Stents Market Facts & Figures by Type 6.3 North America Drug-Eluting Bioabsorbable Stents Market Facts & Figures by Application 7 Europe 7.1 Europe Drug-Eluting Bioabsorbable Stents by Country 7.1.1 Europe Drug-Eluting Bioabsorbable Stents Sales by Country 7.1.2 Europe Drug-Eluting Bioabsorbable Stents Revenue by Country 7.1.3 Germany 7.1.4 France 7.1.5 U.K. 7.1.6 Italy 7.1.7 Russia 7.2 Europe Drug-Eluting Bioabsorbable Stents Market Facts & Figures by Type 7.3 Europe Drug-Eluting Bioabsorbable Stents Market Facts & Figures by Application 8 Asia Pacific 8.1 Asia Pacific Drug-Eluting Bioabsorbable Stents by Region 8.1.1 Asia Pacific Drug-Eluting Bioabsorbable Stents Sales by Region 8.1.2 Asia Pacific Drug-Eluting Bioabsorbable Stents Revenue by Region 8.1.3 China 8.1.4 Japan 8.1.5 South Korea 8.1.6 India 8.1.7 Australia 8.1.8 Taiwan 8.1.9 Indonesia 8.1.10 Thailand 8.1.11 Malaysia 8.1.12 Philippines 8.1.13 Vietnam 8.2 Asia Pacific Drug-Eluting Bioabsorbable Stents Market Facts & Figures by Type 8.3 Asia Pacific Drug-Eluting Bioabsorbable Stents Market Facts & Figures by Application 9 Latin America 9.1 Latin America Drug-Eluting Bioabsorbable Stents by Country 9.1.1 Latin America Drug-Eluting Bioabsorbable Stents Sales by Country 9.1.2 Latin America Drug-Eluting Bioabsorbable Stents Revenue by Country 9.1.3 Mexico 9.1.4 Brazil 9.1.5 Argentina 9.2 Central & South America Drug-Eluting Bioabsorbable Stents Market Facts & Figures by Type 9.3 Central & South America Drug-Eluting Bioabsorbable Stents Market Facts & Figures by Application 10 Middle East and Africa 10.1 Middle East and Africa Drug-Eluting Bioabsorbable Stents by Country 10.1.1 Middle East and Africa Drug-Eluting Bioabsorbable Stents Sales by Country 10.1.2 Middle East and Africa Drug-Eluting Bioabsorbable Stents Revenue by Country 10.1.3 Turkey 10.1.4 Saudi Arabia 10.1.5 U.A.E 10.2 Middle East and Africa Drug-Eluting Bioabsorbable Stents Market Facts & Figures by Type 10.3 Middle East and Africa Drug-Eluting Bioabsorbable Stents Market Facts & Figures by Application 11 Company Profiles 11.1 Medtronic 11.1.1 Medtronic Corporation Information 11.1.2 Medtronic Description and Business Overview 11.1.3 Medtronic Sales, Revenue and Gross Margin (2015-2020) 11.1.4 Medtronic Drug-Eluting Bioabsorbable Stents Products Offered 11.1.5 Medtronic Related Developments 11.2 B.Braun Melsungen 11.2.1 B.Braun Melsungen Corporation Information 11.2.2 B.Braun Melsungen Description and Business Overview 11.2.3 B.Braun Melsungen Sales, Revenue and Gross Margin (2015-2020) 11.2.4 B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Products Offered 11.2.5 B.Braun Melsungen Related Developments 11.3 Abbott Laboratories 11.3.1 Abbott Laboratories Corporation Information 11.3.2 Abbott Laboratories Description and Business Overview 11.3.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020) 11.3.4 Abbott Laboratories Drug-Eluting Bioabsorbable Stents Products Offered 11.3.5 Abbott Laboratories Related Developments 11.4 Boston Scientific Corporation 11.4.1 Boston Scientific Corporation Corporation Information 11.4.2 Boston Scientific Corporation Description and Business Overview 11.4.3 Boston Scientific Corporation Sales, Revenue and Gross Margin (2015-2020) 11.4.4 Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Products Offered 11.4.5 Boston Scientific Corporation Related Developments 11.5 Biosensors International 11.5.1 Biosensors International Corporation Information 11.5.2 Biosensors International Description and Business Overview 11.5.3 Biosensors International Sales, Revenue and Gross Margin (2015-2020) 11.5.4 Biosensors International Drug-Eluting Bioabsorbable Stents Products Offered 11.5.5 Biosensors International Related Developments 11.6 Terumo Corporation. 11.6.1 Terumo Corporation. Corporation Information 11.6.2 Terumo Corporation. Description and Business Overview 11.6.3 Terumo Corporation. Sales, Revenue and Gross Margin (2015-2020) 11.6.4 Terumo Corporation. Drug-Eluting Bioabsorbable Stents Products Offered 11.6.5 Terumo Corporation. Related Developments 11.7 MicroPort Scientific Corporation 11.7.1 MicroPort Scientific Corporation Corporation Information 11.7.2 MicroPort Scientific Corporation Description and Business Overview 11.7.3 MicroPort Scientific Corporation Sales, Revenue and Gross Margin (2015-2020) 11.7.4 MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Products Offered 11.7.5 MicroPort Scientific Corporation Related Developments 11.8 Alvimedica 11.8.1 Alvimedica Corporation Information 11.8.2 Alvimedica Description and Business Overview 11.8.3 Alvimedica Sales, Revenue and Gross Margin (2015-2020) 11.8.4 Alvimedica Drug-Eluting Bioabsorbable Stents Products Offered 11.8.5 Alvimedica Related Developments 11.9 Biotronik 11.9.1 Biotronik Corporation Information 11.9.2 Biotronik Description and Business Overview 11.9.3 Biotronik Sales, Revenue and Gross Margin (2015-2020) 11.9.4 Biotronik Drug-Eluting Bioabsorbable Stents Products Offered 11.9.5 Biotronik Related Developments 11.10 Elixir Medical Corporation 11.10.1 Elixir Medical Corporation Corporation Information 11.10.2 Elixir Medical Corporation Description and Business Overview 11.10.3 Elixir Medical Corporation Sales, Revenue and Gross Margin (2015-2020) 11.10.4 Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Products Offered 11.10.5 Elixir Medical Corporation Related Developments 11.1 Medtronic 11.1.1 Medtronic Corporation Information 11.1.2 Medtronic Description and Business Overview 11.1.3 Medtronic Sales, Revenue and Gross Margin (2015-2020) 11.1.4 Medtronic Drug-Eluting Bioabsorbable Stents Products Offered 11.1.5 Medtronic Related Developments 12 Future Forecast by Regions (Countries) (2021-2026) 12.1 Drug-Eluting Bioabsorbable Stents Market Estimates and Projections by Region 12.1.1 Global Drug-Eluting Bioabsorbable Stents Sales Forecast by Regions 2021-2026 12.1.2 Global Drug-Eluting Bioabsorbable Stents Revenue Forecast by Regions 2021-2026 12.2 North America Drug-Eluting Bioabsorbable Stents Market Size Forecast (2021-2026) 12.2.1 North America: Drug-Eluting Bioabsorbable Stents Sales Forecast (2021-2026) 12.2.2 North America: Drug-Eluting Bioabsorbable Stents Revenue Forecast (2021-2026) 12.2.3 North America: Drug-Eluting Bioabsorbable Stents Market Size Forecast by Country (2021-2026) 12.3 Europe Drug-Eluting Bioabsorbable Stents Market Size Forecast (2021-2026) 12.3.1 Europe: Drug-Eluting Bioabsorbable Stents Sales Forecast (2021-2026) 12.3.2 Europe: Drug-Eluting Bioabsorbable Stents Revenue Forecast (2021-2026) 12.3.3 Europe: Drug-Eluting Bioabsorbable Stents Market Size Forecast by Country (2021-2026) 12.4 Asia Pacific Drug-Eluting Bioabsorbable Stents Market Size Forecast (2021-2026) 12.4.1 Asia Pacific: Drug-Eluting Bioabsorbable Stents Sales Forecast (2021-2026) 12.4.2 Asia Pacific: Drug-Eluting Bioabsorbable Stents Revenue Forecast (2021-2026) 12.4.3 Asia Pacific: Drug-Eluting Bioabsorbable Stents Market Size Forecast by Region (2021-2026) 12.5 Latin America Drug-Eluting Bioabsorbable Stents Market Size Forecast (2021-2026) 12.5.1 Latin America: Drug-Eluting Bioabsorbable Stents Sales Forecast (2021-2026) 12.5.2 Latin America: Drug-Eluting Bioabsorbable Stents Revenue Forecast (2021-2026) 12.5.3 Latin America: Drug-Eluting Bioabsorbable Stents Market Size Forecast by Country (2021-2026) 12.6 Middle East and Africa Drug-Eluting Bioabsorbable Stents Market Size Forecast (2021-2026) 12.6.1 Middle East and Africa: Drug-Eluting Bioabsorbable Stents Sales Forecast (2021-2026) 12.6.2 Middle East and Africa: Drug-Eluting Bioabsorbable Stents Revenue Forecast (2021-2026) 12.6.3 Middle East and Africa: Drug-Eluting Bioabsorbable Stents Market Size Forecast by Country (2021-2026) 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Porter's Five Forces Analysis 13.5 Primary Interviews with Key Drug-Eluting Bioabsorbable Stents Players (Opinion Leaders) 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Drug-Eluting Bioabsorbable Stents Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Drug-Eluting Bioabsorbable Stents Market Segments Table 2. Ranking of Global Top Drug-Eluting Bioabsorbable Stents Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global Drug-Eluting Bioabsorbable Stents Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million) Table 4. Major Manufacturers of Serolimus and Paclitaxel Drug-Eluting Stents Table 5. Major Manufacturers of Sirolimus Drug Eluting Stents Table 6. Global Drug-Eluting Bioabsorbable Stents Market Size Growth Rate by Application 2020-2026 (K Units) Table 7. Global Drug-Eluting Bioabsorbable Stents Market Size by Region (K Units) & (US$ Million): 2020 VS 2026 Table 8. Global Drug-Eluting Bioabsorbable Stents Sales by Regions 2015-2020 (K Units) Table 9. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Regions (2015-2020) Table 10. Global Drug-Eluting Bioabsorbable Stents Revenue by Regions 2015-2020 (US$ Million) Table 11. Global Drug-Eluting Bioabsorbable Stents Sales by Manufacturers (2015-2020) (K Units) Table 12. Global Drug-Eluting Bioabsorbable Stents Sales Share by Manufacturers (2015-2020) Table 13. Global Drug-Eluting Bioabsorbable Stents Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020) Table 14. Global Drug-Eluting Bioabsorbable Stents by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug-Eluting Bioabsorbable Stents as of 2019) Table 15. Drug-Eluting Bioabsorbable Stents Revenue by Manufacturers (2015-2020) (US$ Million) Table 16. Drug-Eluting Bioabsorbable Stents Revenue Share by Manufacturers (2015-2020) Table 17. Key Manufacturers Drug-Eluting Bioabsorbable Stents Price (2015-2020) (USD/Unit) Table 18. Drug-Eluting Bioabsorbable Stents Manufacturers Manufacturing Base Distribution and Headquarters Table 19. Manufacturers Drug-Eluting Bioabsorbable Stents Product Type Table 20. Date of International Manufacturers Enter into Drug-Eluting Bioabsorbable Stents Market Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans Table 22. Global Drug-Eluting Bioabsorbable Stents Sales by Type (2015-2020) (K Units) Table 23. Global Drug-Eluting Bioabsorbable Stents Sales Share by Type (2015-2020) Table 24. Global Drug-Eluting Bioabsorbable Stents Revenue by Type (2015-2020) (US$ Million) Table 25. Global Drug-Eluting Bioabsorbable Stents Revenue Share by Type (2015-2020) Table 26. Drug-Eluting Bioabsorbable Stents Average Selling Price (ASP) by Type 2015-2020 (USD/Unit) Table 27. Global Drug-Eluting Bioabsorbable Stents Sales by Application (2015-2020) (K Units) Table 28. Global Drug-Eluting Bioabsorbable Stents Sales Share by Application (2015-2020) Table 29. North America Drug-Eluting Bioabsorbable Stents Sales by Country (2015-2020) (K Units) Table 30. North America Drug-Eluting Bioabsorbable Stents Sales Market Share by Country (2015-2020) Table 31. North America Drug-Eluting Bioabsorbable Stents Revenue by Country (2015-2020) (US$ Million) Table 32. North America Drug-Eluting Bioabsorbable Stents Revenue Market Share by Country (2015-2020) Table 33. North America Drug-Eluting Bioabsorbable Stents Sales by Type (2015-2020) (K Units) Table 34. North America Drug-Eluting Bioabsorbable Stents Sales Market Share by Type (2015-2020) Table 35. North America Drug-Eluting Bioabsorbable Stents Sales by Application (2015-2020) (K Units) Table 36. North America Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2015-2020) Table 37. Europe Drug-Eluting Bioabsorbable Stents Sales by Country (2015-2020) (K Units) Table 38. Europe Drug-Eluting Bioabsorbable Stents Sales Market Share by Country (2015-2020) Table 39. Europe Drug-Eluting Bioabsorbable Stents Revenue by Country (2015-2020) (US$ Million) Table 40. Europe Drug-Eluting Bioabsorbable Stents Revenue Market Share by Country (2015-2020) Table 41. Europe Drug-Eluting Bioabsorbable Stents Sales by Type (2015-2020) (K Units) Table 42. Europe Drug-Eluting Bioabsorbable Stents Sales Market Share by Type (2015-2020) Table 43. Europe Drug-Eluting Bioabsorbable Stents Sales by Application (2015-2020) (K Units) Table 44. Europe Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2015-2020) Table 45. Asia Pacific Drug-Eluting Bioabsorbable Stents Sales by Region (2015-2020) (K Units) Table 46. Asia Pacific Drug-Eluting Bioabsorbable Stents Sales Market Share by Region (2015-2020) Table 47. Asia Pacific Drug-Eluting Bioabsorbable Stents Revenue by Region (2015-2020) (US$ Million) Table 48. Asia Pacific Drug-Eluting Bioabsorbable Stents Revenue Market Share by Region (2015-2020) Table 49. Asia Pacific Drug-Eluting Bioabsorbable Stents Sales by Type (2015-2020) (K Units) Table 50. Asia Pacific Drug-Eluting Bioabsorbable Stents Sales Market Share by Type (2015-2020) Table 51. Asia Pacific Drug-Eluting Bioabsorbable Stents Sales by Application (2015-2020) (K Units) Table 52. Asia Pacific Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2015-2020) Table 53. Latin America Drug-Eluting Bioabsorbable Stents Sales by Country (2015-2020) (K Units) Table 54. Latin America Drug-Eluting Bioabsorbable Stents Sales Market Share by Country (2015-2020) Table 55. Latin Americaa Drug-Eluting Bioabsorbable Stents Revenue by Country (2015-2020) (US$ Million) Table 56. Latin America Drug-Eluting Bioabsorbable Stents Revenue Market Share by Country (2015-2020) Table 57. Latin America Drug-Eluting Bioabsorbable Stents Sales by Type (2015-2020) (K Units) Table 58. Latin America Drug-Eluting Bioabsorbable Stents Sales Market Share by Type (2015-2020) Table 59. Latin America Drug-Eluting Bioabsorbable Stents Sales by Application (2015-2020) (K Units) Table 60. Latin America Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2015-2020) Table 61. Middle East and Africa Drug-Eluting Bioabsorbable Stents Sales by Country (2015-2020) (K Units) Table 62. Middle East and Africa Drug-Eluting Bioabsorbable Stents Sales Market Share by Country (2015-2020) Table 63. Middle East and Africa Drug-Eluting Bioabsorbable Stents Revenue by Country (2015-2020) (US$ Million) Table 64. Middle East and Africa Drug-Eluting Bioabsorbable Stents Revenue Market Share by Country (2015-2020) Table 65. Middle East and Africa Drug-Eluting Bioabsorbable Stents Sales by Type (2015-2020) (K Units) Table 66. Middle East and Africa Drug-Eluting Bioabsorbable Stents Sales Market Share by Type (2015-2020) Table 67. Middle East and Africa Drug-Eluting Bioabsorbable Stents Sales by Application (2015-2020) (K Units) Table 68. Middle East and Africa Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2015-2020) Table 69. Medtronic Corporation Information Table 70. Medtronic Description and Major Businesses Table 71. Medtronic Drug-Eluting Bioabsorbable Stents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 72. Medtronic Product Table 73. Medtronic Recent Development Table 74. B.Braun Melsungen Corporation Information Table 75. B.Braun Melsungen Description and Major Businesses Table 76. B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 77. B.Braun Melsungen Product Table 78. B.Braun Melsungen Recent Development Table 79. Abbott Laboratories Corporation Information Table 80. Abbott Laboratories Description and Major Businesses Table 81. Abbott Laboratories Drug-Eluting Bioabsorbable Stents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 82. Abbott Laboratories Product Table 83. Abbott Laboratories Recent Development Table 84. Boston Scientific Corporation Corporation Information Table 85. Boston Scientific Corporation Description and Major Businesses Table 86. Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 87. Boston Scientific Corporation Product Table 88. Boston Scientific Corporation Recent Development Table 89. Biosensors International Corporation Information Table 90. Biosensors International Description and Major Businesses Table 91. Biosensors International Drug-Eluting Bioabsorbable Stents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 92. Biosensors International Product Table 93. Biosensors International Recent Development Table 94. Terumo Corporation. Corporation Information Table 95. Terumo Corporation. Description and Major Businesses Table 96. Terumo Corporation. Drug-Eluting Bioabsorbable Stents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 97. Terumo Corporation. Product Table 98. Terumo Corporation. Recent Development Table 99. MicroPort Scientific Corporation Corporation Information Table 100. MicroPort Scientific Corporation Description and Major Businesses Table 101. MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 102. MicroPort Scientific Corporation Product Table 103. MicroPort Scientific Corporation Recent Development Table 104. Alvimedica Corporation Information Table 105. Alvimedica Description and Major Businesses Table 106. Alvimedica Drug-Eluting Bioabsorbable Stents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 107. Alvimedica Product Table 108. Alvimedica Recent Development Table 109. Biotronik Corporation Information Table 110. Biotronik Description and Major Businesses Table 111. Biotronik Drug-Eluting Bioabsorbable Stents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 112. Biotronik Product Table 113. Biotronik Recent Development Table 114. Elixir Medical Corporation Corporation Information Table 115. Elixir Medical Corporation Description and Major Businesses Table 116. Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 117. Elixir Medical Corporation Product Table 118. Elixir Medical Corporation Recent Development Table 119. Innovative Health Technologies Corporation Information Table 120. Innovative Health Technologies Description and Major Businesses Table 121. Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 122. Innovative Health Technologies Product Table 123. Innovative Health Technologies Recent Development Table 124. Global Drug-Eluting Bioabsorbable Stents Sales Forecast by Regions (2021-2026) (K Units) Table 125. Global Drug-Eluting Bioabsorbable Stents Sales Market Share Forecast by Regions (2021-2026) Table 126. Global Drug-Eluting Bioabsorbable Stents Revenue Forecast by Regions (2021-2026) (US$ Million) Table 127. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share Forecast by Regions (2021-2026) Table 128. North America: Drug-Eluting Bioabsorbable Stents Sales Forecast by Country (2021-2026) (K Units) Table 129. North America: Drug-Eluting Bioabsorbable Stents Revenue Forecast by Country (2021-2026) (US$ Million) Table 130. Europe: Drug-Eluting Bioabsorbable Stents Sales Forecast by Country (2021-2026) (K Units) Table 131. Europe: Drug-Eluting Bioabsorbable Stents Revenue Forecast by Country (2021-2026) (US$ Million) Table 132. Asia Pacific: Drug-Eluting Bioabsorbable Stents Sales Forecast by Region (2021-2026) (K Units) Table 133. Asia Pacific: Drug-Eluting Bioabsorbable Stents Revenue Forecast by Region (2021-2026) (US$ Million) Table 134. Latin America: Drug-Eluting Bioabsorbable Stents Sales Forecast by Country (2021-2026) (K Units) Table 135. Latin America: Drug-Eluting Bioabsorbable Stents Revenue Forecast by Country (2021-2026) (US$ Million) Table 136. Middle East and Africa: Drug-Eluting Bioabsorbable Stents Sales Forecast by Country (2021-2026) (K Units) Table 137. Middle East and Africa: Drug-Eluting Bioabsorbable Stents Revenue Forecast by Country (2021-2026) (US$ Million) Table 138. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 139. Key Challenges Table 140. Market Risks Table 141. Main Points Interviewed from Key Drug-Eluting Bioabsorbable Stents Players Table 142. Drug-Eluting Bioabsorbable Stents Customers List Table 143. Drug-Eluting Bioabsorbable Stents Distributors List Table 144. Research Programs/Design for This Report Table 145. Key Data Information from Secondary Sources Table 146. Key Data Information from Primary Sources List of Figures Figure 1. Drug-Eluting Bioabsorbable Stents Product Picture Figure 2. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Type in 2020 & 2026 Figure 3. Serolimus and Paclitaxel Drug-Eluting Stents Product Picture Figure 4. Sirolimus Drug Eluting Stents Product Picture Figure 5. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Application in 2020 & 2026 Figure 6. Coronary Artery Diseases Figure 7. Peripheral Artery Diseases Figure 8. Drug-Eluting Bioabsorbable Stents Report Years Considered Figure 9. Global Drug-Eluting Bioabsorbable Stents Market Size 2015-2026 (US$ Million) Figure 10. Global Drug-Eluting Bioabsorbable Stents Sales 2015-2026 (K Units) Figure 11. Global Drug-Eluting Bioabsorbable Stents Market Size Market Share by Region: 2020 Versus 2026 Figure 12. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Region (2015-2020) Figure 13. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Region in 2019 Figure 14. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Region (2015-2020) Figure 15. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Region in 2019 Figure 16. Global Drug-Eluting Bioabsorbable Stents Sales Share by Manufacturer in 2019 Figure 17. The Top 10 and 5 Players Market Share by Drug-Eluting Bioabsorbable Stents Revenue in 2019 Figure 18. Drug-Eluting Bioabsorbable Stents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 19. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Type (2015-2020) Figure 20. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Type in 2019 Figure 21. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Type (2015-2020) Figure 22. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Type in 2019 Figure 23. Global Drug-Eluting Bioabsorbable Stents Market Share by Price Range (2015-2020) Figure 24. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2015-2020) Figure 25. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Application in 2019 Figure 26. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Application (2015-2020) Figure 27. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Application in 2019 Figure 28. North America Drug-Eluting Bioabsorbable Stents Sales Growth Rate 2015-2020 (K Units) Figure 29. North America Drug-Eluting Bioabsorbable Stents Revenue Growth Rate 2015-2020 (US$ Million) Figure 30. North America Drug-Eluting Bioabsorbable Stents Sales Market Share by Country in 2019 Figure 31. North America Drug-Eluting Bioabsorbable Stents Revenue Market Share by Country in 2019 Figure 32. U.S. Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units) Figure 33. U.S. Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million) Figure 34. Canada Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units) Figure 35. Canada Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million) Figure 36. North America Drug-Eluting Bioabsorbable Stents Market Share by Type in 2019 Figure 37. North America Drug-Eluting Bioabsorbable Stents Market Share by Application in 2019 Figure 38. Europe Drug-Eluting Bioabsorbable Stents Sales Growth Rate 2015-2020 (K Units) Figure 39. Europe Drug-Eluting Bioabsorbable Stents Revenue Growth Rate 2015-2020 (US$ Million) Figure 40. Europe Drug-Eluting Bioabsorbable Stents Sales Market Share by Country in 2019 Figure 41. Europe Drug-Eluting Bioabsorbable Stents Revenue Market Share by Country in 2019 Figure 42. Germany Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units) Figure 43. Germany Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million) Figure 44. France Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units) Figure 45. France Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million) Figure 46. U.K. Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units) Figure 47. U.K. Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million) Figure 48. Italy Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units) Figure 49. Italy Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million) Figure 50. Russia Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units) Figure 51. Russia Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million) Figure 52. Europe Drug-Eluting Bioabsorbable Stents Market Share by Type in 2019 Figure 53. Europe Drug-Eluting Bioabsorbable Stents Market Share by Application in 2019 Figure 54. Asia Pacific Drug-Eluting Bioabsorbable Stents Sales Growth Rate 2015-2020 (K Units) Figure 55. Asia Pacific Drug-Eluting Bioabsorbable Stents Revenue Growth Rate 2015-2020 (US$ Million) Figure 56. Asia Pacific Drug-Eluting Bioabsorbable Stents Sales Market Share by Region in 2019 Figure 57. Asia Pacific Drug-Eluting Bioabsorbable Stents Revenue Market Share by Region in 2019 Figure 58. China Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units) Figure 59. China Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million) Figure 60. Japan Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units) Figure 61. Japan Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million) Figure 62. South Korea Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units) Figure 63. South Korea Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million) Figure 64. India Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units) Figure 65. India Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million) Figure 66. Australia Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units) Figure 67. Australia Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million) Figure 68. Taiwan Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units) Figure 69. Taiwan Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million) Figure 70. Indonesia Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units) Figure 71. Indonesia Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million) Figure 72. Thailand Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units) Figure 73. Thailand Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million) Figure 74. Malaysia Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units) Figure 75. Malaysia Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million) Figure 76. Philippines Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units) Figure 77. Philippines Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million) Figure 78. Vietnam Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units) Figure 79. Vietnam Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million) Figure 80. Asia Pacific Drug-Eluting Bioabsorbable Stents Market Share by Type in 2019 Figure 81. Asia Pacific Drug-Eluting Bioabsorbable Stents Market Share by Application in 2019 Figure 82. Latin America Drug-Eluting Bioabsorbable Stents Sales Growth Rate 2015-2020 (K Units) Figure 83. Latin America Drug-Eluting Bioabsorbable Stents Revenue Growth Rate 2015-2020 (US$ Million) Figure 84. Latin America Drug-Eluting Bioabsorbable Stents Sales Market Share by Country in 2019 Figure 85. Latin America Drug-Eluting Bioabsorbable Stents Revenue Market Share by Country in 2019 Figure 86. Mexico Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units) Figure 87. Mexico Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million) Figure 88. Brazil Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units) Figure 89. Brazil Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million) Figure 90. Argentina Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units) Figure 91. Argentina Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million) Figure 92. Latin America Drug-Eluting Bioabsorbable Stents Market Share by Type in 2019 Figure 93. Latin America Drug-Eluting Bioabsorbable Stents Market Share by Application in 2019 Figure 94. Middle East and Africa Drug-Eluting Bioabsorbable Stents Sales Growth Rate 2015-2020 (K Units) Figure 95. Middle East and Africa Drug-Eluting Bioabsorbable Stents Revenue Growth Rate 2015-2020 (US$ Million) Figure 96. Middle East and Africa Drug-Eluting Bioabsorbable Stents Sales Market Share by Country in 2019 Figure 97. Middle East and Africa Drug-Eluting Bioabsorbable Stents Revenue Market Share by Country in 2019 Figure 98. Turkey Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units) Figure 99. Turkey Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million) Figure 100. Saudi Arabia Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units) Figure 101. Saudi Arabia Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million) Figure 102. U.A.E Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units) Figure 103. U.A.E Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million) Figure 104. Middle East and Africa Drug-Eluting Bioabsorbable Stents Market Share by Type in 2019 Figure 105. Middle East and Africa Drug-Eluting Bioabsorbable Stents Market Share by Application in 2019 Figure 106. North America Drug-Eluting Bioabsorbable Stents Sales Growth Rate Forecast (2021-2026) (K Units) Figure 107. North America Drug-Eluting Bioabsorbable Stents Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 108. Europe Drug-Eluting Bioabsorbable Stents Sales Growth Rate Forecast (2021-2026) (K Units) Figure 109. Europe Drug-Eluting Bioabsorbable Stents Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 110. Asia Pacific Drug-Eluting Bioabsorbable Stents Sales Growth Rate Forecast (2021-2026) (K Units) Figure 111. Asia Pacific Drug-Eluting Bioabsorbable Stents Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 112. Latin America Drug-Eluting Bioabsorbable Stents Sales Growth Rate Forecast (2021-2026) (K Units) Figure 113. Latin America Drug-Eluting Bioabsorbable Stents Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 114. Middle East and Africa Drug-Eluting Bioabsorbable Stents Sales Growth Rate Forecast (2021-2026) (K Units) Figure 115. Middle East and Africa Drug-Eluting Bioabsorbable Stents Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 116. Porter's Five Forces Analysis Figure 117. Channels of Distribution Figure 118. Distributors Profiles Figure 119. Bottom-up and Top-down Approaches for This Report Figure 120. Data Triangulation Figure 121. Key Executives Interviewed